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Neck Circumference Correlates to Coronary 
Calcification Better Than BMI and Waist 
Circumference in Insulin Resistance Obese Subjects
Antonia A Lukito,1,2,3 Andi Wijaya,1Peter Kabo,1 Syakib Bakri1
T�e associa�ion o� obesi�y, insulin resis�ance, and c�ronic low-grade in�la�-
�a�ion �as been eviden� �or years.Nec� circu��erence(NC), a para�e�er o� 
subcu�aneous �a�, is a unique s�orage depo� and allegedly �as an addi�ional 
role �or cardiovascular ris� beyond ��e e��ec� o� abdo�inal circu��erence.
Vascular calci�ica�ion is iden�i�ied a� early s�age o� a��erosclerosis and as-
socia�ed wi�� cardiovascular even�s. T�e degree o� calci�ica�ion associa�ed 
wi�� local vascular in�la��a�ion and progression o� a��erosclerosis, How-
ever, ��ere is no s�udy lin�ing NC independen�ly �o coronary calci�ica�ion, 
an es�ablis�ed para�e�er o� subclinical a��erosclerosis. T�is s�udy carried 
ou� 60 obese non-diabe�es �en, consis�ed o� 30 insulin-resis�an�(I�) and 
30 non insulin-resis�an�(NI�) sub�ec�s.T�ere was no correla�ion be�ween 
conven�ional cardiovascular ris� �ac�ors wi�� NCorcoronary ar�ery cal-
ciu� (CAC) score, in bo�� I� and NI� sub�ec�s.In I� sub�ec�s,��ere was 
a signi�ican� posi�ive correla�ion be�ween CAC score wi�� NC, bu� none 
be�ween CAC score wi�� body �ass index (BMI) or wais� circu��erence.A 
signi�ican� correla�ion was �ound be�ween �s-C�� wi�� CAC score orNC in 
I� sub�ec�s, bu� none in NI� sub�ec�s.In�eres�ingly, ��e correla�ion be�ween 
NCand CAC scorein I� sub�ec�s re�ained signi�ican� a��er eac� o� BMI, 
�s-C��, HOMA-I�, lep�inoradiponec�inbeingad�us�ed, lead �o sugges�ion o� 
ano��er �ec�anis�s �ig�� involve in ��e pa��o-�ec�anis�s o� coronary 
calci�ica�ion in upper body obesi�y sub�ec�s. We concluded, in non-diabe�ic 
I�obese �ale individuals, NC is associa�ed wi�� coronary calci�ica�ion, 
beyond ��e e��ec� o� BMI, low-grade in�la��a�ion, ��e degree o� insulin 
resis�ance and adipo�ines suc� as lep�in and adiponec�in.
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Obesity is a preventable leading cause of death, with 
increasing prevalence in adults and children, and has 
been designated as one of the serious public health 
problem in the 21st century.Obesity is a condition 
of excessive body fataccumulation that reflects the 
complex pathological process involving metabolic, 
Hubungan antara obesitas, resistensi insulin dan inflamasi kronis derajat rendah telah lama diketahui. Lingkar leher (LL), suatu 
parameter lemak subkutan, merupakan depo lemak unik yang meningkatkan risiko kardiovaskular di luar efek lingkar perut. 
Kalsifikasi koroner teridentifikasi pada awal aterosklerosis dan berkaitan dengan kejadian kardiovaskular. Derajat kalsifikasi ber-
hubungan dengan inflamasi vaskular lokal dan laju aterosklerosis, namun, belum ada studi yang meneliti hubungan LL dengan 
kalsifikasi koroner, suatu parameter aterosklerosis subklinis. Subyek studi ini adalah 60 pria obes non diabetes, terdiri dari 30 
subyek insulin-resisten(IR) dan 30 non insulin-resisten(NIR).  Tak didapatkan korelasi antara faktor-faktor risiko konvensional 
dengan LL ataupun skor kalsium arteri koroner (KAK), pada subyek IR maupun NIR. Pada subyek IR, ditemukan korelasi 
positif bermakna antara skor KAK dengan LL, namun tak ditemukan korelasi dengan indeks masa tubuh (IMT) atau lingkar 
perut. Juga ditemukan korelasi bermakna antara hs-CRP dengan skor KAK atau LL hanya pada subyek IR. Korelasi antara 
LL dan skor KAK pada subyek IR tetap bermakna setelah masing-masing IMT, hs-CRP, HOMA-IR, leptin atau adiponektin 
dikendalikan, menimbulkan dugaan adanya mekanisme lain dalam proses kalsifikasi koroner pada subyek obesitas tubuh bagian 
atas. Sebagai konklusi, pada individu obes non diabetik dengan resistensi insulin, LL berhubungan dengan kalsifikasi koroner, 
diluar pengaruh IMT, inflamasi derajat rendah, derajat resistensi insulin atau adipokin seperti leptin dan adiponektin.
(J Kardiol Indones. 2012;33:65-72)
Kata kunci: lingkar leher,kalsifikasi koroner,resistensi insulin, inflamasi, obesitas
Korelasi lingkar leher terhadap kalsifikasi 
koroner lebih baik daripada IMT dan lingkar 
pinggang pada subyek obesitas resisten insulin
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environmental and genetic interactions, whichlower 
life expectancy and increases the risk of various diseases, 
especially heart disease, type-2 DM, obstructive sleep 
apnea (OSA), cancer and osteoarthritis.1
The classical perception of adipose tissue as a storage 
place of fatty acids has been replaced over the last years 
by the notion that adipose tissue has a central role in 
lipid and glucose metabolism and produces a large 
number of hormones and cytokines involved in the 
development of metabolic syndrome, diabetes mellitus 
and vascular disease . Obesity is a status of low-grade 
and chronic inflammation caused by dysfunction of 
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adipocytes and macrophages. Adipocytes dysfunction 
is a condition of hypersecretion of adipokines that are 
pro-atherogenic, pro-inflamatoris and pro-diabetic 
(i.e. leptin) accompanied by decreased production of 
adiponectin. Both adipocytes and macrophages in fat 
tissue secretes a number of cytokines which are then 
released into the circulation, stimulates the hepatic 
production of CRP, known as markers of systemic 
inflammation.2
Vascular calcification was once regarded as a passive 
degenerative process and an inevitable result of mineral 
deposition in the vascular wall and occurred at an 
advanced stage of atherosclerosis. However, recent 
studies identify vascular calcification at an early stage 
of atherosclerosis and are associated with cardiovascular 
events. The degree of calcification associated with 
local vascular inflammation and progression of 
atherosclerosis, Over the last decade, diverse and highly 
regulated molecular signaling cascades controlling 
vascular calcification have been described.3, 4
Visceral fat tissue has been recognized as a unique 
and pathogenic fat depot, contribute to the metabolic 
risk beyond standard anthropometric measurements, 
such as body mass index (BMI) and abdominal 
circumference.5Individuals with excess visceral fat are 
at increased risk of insulin resistance, type 2 diabetes 
(diabetes mellitus type-2) and atherosclerosis. But 
apparently visceral adipose tissue was only moderately 
correlated with cardiometabolic risk factors, suggested 
another mechanism or other fat depots may have a 
role. 
Neck circumference, a parameter of subcutaneous 
fat on the human body, is a unique storage depot and 
allegedly has an additional role for cardiovascular risk 
beyond the effect of abdominal circumference.5One 
third of the population with insulin-resistant 
high risk of cardiovascular disease. The more 
overweight/obese the person, the more likely they 
are to be insulin-resistant and at increased risk of 
cardiovascular disease, but substantial numbers 
of overweight/obese individuals remain insulin-
sensitive, and not all insulin-resistant persons are 
obese. Of greater clinical relevance is evidence 
that the metabolic benefit and decrease in risk of 
cardiovascular disease following weight loss occurs 
primarily in those overweight/obese individuals that 
are also insulin-resistant.5
However, there is no study linking neck circum-
ference independently to coronary calcification, an 
established parameter of subclinical atherosclerosis.
Methods
The research was conducted in Siloam HospitalLippo 
Village, Faculty of Medicine, Pelita Harapan 
University,Tangerang using cross-sectional design 
andconsecutive samplingrecruitment. The study 
subjects were non-diabetic obese men who came to 
the radiology department for evaluation of coronary 
artery calcium score and met the inclusion criteria 
as follows; age ≥ 45 years, BMI ≥ 25kg/m2 and/
or abdominal circumference ≥ 90cm (WHO Asia 
Pacific criteria 2000),abnormal coronary calcium 
score> 10 Agatston units, no evidence of diabetes, 
chronic renal disease nor impaired liver enzymes, no 
history of coronary stent implantation and/or coronary 
bypass surgery, oral anticoagulant naive, not in acute 
inflammation and are willing to participate in the study 
by signing an informed consent.Insulin resistance was 
obtained from the calculation of the formula HOMA-
IR (GxI/22.5) (G = fasting glucose concentration 
mmol / L, I. = insulin concentration μU / mL). As 
there is no standarad cutoff value of HOMA-IR, 
and the valuediffers  on races and ethnics, the study 
will use median value  as cutoff value to distinguish 
subjects with insulin resistance and without insulin 
resistance.Leptin serum concentration (ng / ml) were 
measured by ELISA method (Linco Research) with a 
normal value of 2-8 g / L.6, 7 Adipokinektin plasma 
concentrations (ng / ml) was measured by ELISA 
method (Linco Research) with a normal value of 
3-30 mg / mL.6, 7Coronary calcium scoringperformed 
bydual-source 64-slice computed tomography scanner 
(Siemens) with prospective electrocardiographic gating 
during a single breath resistance (7 seconds) with 
sequential data acquisition with 3mm slice thickness. 
Coronary artery calcium (CAC) score were calculated 
in a 130HU detection threshold with semi-automated 
software (syngo calcium scoring, Siemens medical 
solutions). Each data assessed by a technician and read 
by a certified radiologist. Coronary artery calcium score 
is expressed by the modified Agatston score. Abnormal 
coronary artery calcium score  at > 10 Agatston units.8, 
9The neck circumference was measured at the point 
just below the larynx (Adam’s apple) and perpendicular 
to the longitudinal axis of the neck, the tape measure 
did not pass through the surface of the Adam’s 
apple, the subject should look straight ahead during 
measurement, with shoulders upright position (not 
hunched), position the tape measure parallel to the 
floor (in centimeters with one decimal places). Neck 
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circumference ≥ 37 cm in men and ≥ 34 cm in women 
considered to be obese.10
Results
This study was started from July 2010 until May 
2011 and carried out 60 obese non-diabetes male 
subjects and then after further screening, 30 subjects 
with insulin resistance and 30 subjects without insulin 
resistance was found, based on HOMA-IR median 
cutoff value, which is 2.70.
Table 1 showed the description of subjects with 
and without insulin resistance, there was no significant 
differences in coronary artery calcium (CAC) scores, 
blood pressure and lipid profile, except for HDL-
cholesterol, HDL-cholesterol levels appear lower in 
subjects with insulin resistance.
In subjects with insulin resistance, there was a 
significant positive correlation between coronary artery 
calcium score (CAC) with neck circumference (NC), 
while there was no relation found between CAC score 
withbody mass index (BMI)or waist circumference. 
In subjects without insulin resistance, there was no 
correlation found between CAC score withobesity 
measurements, as shown in Table 2.
Further analysis of inflammatory markers (hs-
CRP), adipokines (leptin and adiponectin) and 
degree of insulin resistance (HOMA-IR) with CAC 
scoreor neck circumference (NC), found a significant 








Age year 55.7±6.72 54.7±6.37 0.556
Body Mass Index (BMI) kg/m2 30.2±3.28 27.3±2.59 <0.001
Waist circumference cm 103.1±8.55 98.9±6.70 0.039
Nect circumference (NC) cm 40.9±3.13 39.4±2.39 0.037
Systolic BP mmHg 128.8±15.10 129.8±14.65 0.782
Diastolic BP mmHg 81.6±7.94 82.3±9.35 0.745
Total cholesterol mg/dL 208.5±42.33 207.2±37.09 0.895
LDL-cholesterol mg/dL 131.9±39.04 130.4±34.58 0.870
HDL- cholesterol mg/dL 39.7±5.88 44.7±8.51 0.010
Trigliseride mg/dL 150.8±82.11 141.2±64.95 0.619
HOMA-IR - 4.04±1.07 1.74±0.60 <0.001
Hs-CRP mg/dL 2.58±2.12 2.06±2.18 0.354
Leptin ng/mL 12.38±7.16 9.23±5.08 0.065
Adiponectin ng/mL 3329.5±1287.62 3926. ±1170.77 0.054
CAC Score Agatston Unit 166.3±160.03 180.9±196.53 0.754
BP=blood pressure;HOMA-IR=Homeostasis Model Assessment of Insulin Resistance; hs-CRP=high sensitivity C-reactive Protein; CAC=coronary 
artery calcium
Table 2. Bivariate Correlation between CAC Score and Obesity Measurements in Subjects with Insulin Resistance and 
without Insulin Resistance
CAC Score
Insulin-Resistant (IR) Non Insulin-Resistant (NIR)
R P R P
Neck circumference 0.322* 0.041 -0.260 0.082
Waist circumference 0.212 0.131 -0.219 0.123
Body Mass Index 0.079 0.339 -0.189 0.158
*Spearman bivariate analysis with p value <0.05; CAC=coronary artery calcium
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correlation between hs-CRP with CAC score orNC in 
Insulin-resistant (IR) subjects, but none in non insulin-
resistant(NIR) subjects, as shown in Table 3.
Further analysis found there was no correlation 
between cardiovascular risk factors (blood pressure 
parameters, parameters of lipid profile, smoking, 
exercise and age) with neck circumference orCAC 
score, in both IR and NIR subjects.
Interestingly, the correlation between neck 
circumference and CAC scorein IR subjects remained 
significant after each of body mass index, hs-CRP, 
HOMA-IR, leptinoradiponectinbeingadjusted by the 
Spearman partial analysis, as shown in Table 4.
Discussion
The ability of insulin to mediate glucose disposal 
varies more than six-fold in an apparently healthy 
population, and approximately one third of the most 
insulin-resistant of these individuals are at increased 
risk to develop cardiovascular disease.5In the present 
study, we also found that not all obesity subjects was 
insulin-resistant.
Obesity induces an insulin-resistant state in 
adipose tissue, liver, and muscle and is a strong risk 
factor for the development of type 2 diabetes mellitus. 
Insulin resistance in the setting of obesity results 
from a combination of altered functions of insulin 
target cells and the accumulation of macrophages that 
secrete proinflammatory mediators. At the molecular 
level, insulin resistance is promoted by a transition 
in macrophage polarization from an alternative M2 
activation state maintained by STAT6 and PPARs to 
a classical M1 activation state driven by NF-kappaB, 
AP1, and other signal-dependent transcription factors 
that play crucial roles in innate immunity. Strategies 
focused on inhibiting the inflammation/insulin 
resistance axis that otherwise preserve essential innate 
immune functions may hold promise for therapeutic 
intervention.11
A paradoxical but common finding in the obesity 
clinic is the identification of individuals who can be 
considered ‘inappropriately’ healthy for their degree 
of obesity. Barbarroja et al compared the obese but 
metabolically healthy individuals and equally obese but 
insulin-resistant individuals and indicated that there are 
pathways common to obesity and unrelated to insulin 
resistance and others that are discriminative for insulin 
resistance for a similar degree of obesity, support the 
concept that NIR-MO (non insulin-resistant-morbidly 
obese) individuals lack the inflammatory response that 
characterizes the IR-MO (insulin-resistant-morbidly 
obese) patient and that IL-6, IL-1beta, ERK and 
NF-kappaB are important effectors that mediate the 
inflammation effects promoting insulin resistance12, in 
Table 3. Correlation between Hs-CRP and Adipokines with CAC Score or NC in IR and NIR Subjects
Insulin-Resistant (IR) Non Insulin-Resistant (NIR)
CAC Score Neck circumference CAC Score Neck circumference
R P R P R P R P
Hs-CRP 0.361* 0.025 0.390* 0.016 -0.245 0.065 0.135 0.238
Leptin 0.059 0.378 0.282 0.066 -0.309 0.048 0.237 0.104
Adiponectin -0.146 0.221 -0.203 0.141 -0.072 0.353 0.196 0.149
HOMA-IR -0.148 0.217 0.275 0.070 -0.282 0.065 0.340* 0.033
*Spearman bivariate analysis with significant p value at <0.05; CAC=coronary artery calcium; NC= neck circumference; hs-CRP=high sensitivity C-
reactive Protein; HOMA-IR=Homeostasis Model Assessment of Insulin Resistance
Table 4. Adjusted and Unadjusted Correlation between CAC 
Score and NC in IR Subjects
Correlation between CAC score and NC 
R P
Unadjusted 0.322* <0.05
Hs-CRP adjusted 0.399* <0.05
HOMA-IR adjusted 0.465* <0.05
Leptinadjusted 0.326* <0.05
Adiponectin adjusted 0.445* <0.05
BMI adjusted 0.332* <0.05
*Spearman partial analysis with significant p value at <0.05; CAC=coronary 
artery calcium; IR=Insulin-resistant; NC= neck circumference; hs-CRP=high 
sensitivity C-reactive Protein; HOMA-IR=Homeostasis Model Assessment of 
Insulin Resistance; BMI=body mass index
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this present study we also found that in NIR subject, 
there was no relation between hs-CRP with CAC score 
or neck circumference.13
The association of obesity, insulin resistance, and 
chronic low-grade inflammation has been evident for 
several years by now. Although several molecular and 
cellular mechanisms by which inflammatory events 
decrease the sensitivity to insulin in obese patients 
have recently been elucidated, the pathogenesis of 
obesity-induced insulin resistance is still obscure in 
many aspects. Research currently focuses on adipose 
tissue inflammation as predominantly driven by 
adipose tissue macrophages, but also related alterations 
in other organs (liver, muscle, pancreas) have to be 
considered.14
Obesity was first described as a low-grade 
inflammatory condition more than a decade ago. 
However, it is only relatively recently that obese 
individuals have been described with increased 
macrophage infiltration of adipose tissue, as well as 
an increase in the number of “M1” or “classically 
activated” macrophages. Furthermore, macrophages 
have been identified as the primary source of many 
of the circulating inflammatory molecules that are 
detected in the obese state and are postulated to be 
causal both in the development of insulin resistance 
and in the progression to type 2 diabetes. There 
is evidence that macrophages inhibit adipocyte 
differentiation, potentially leading to adipocyte 
hypertrophy, altered secretion of adipokines and 
ectopic storage of lipid within liver, muscle and other 
non-adipose tissues. Currently, it is not clear what 
causes increased macrophage infiltration of adipose 
tissue in obese individuals. Theories include altered 
signalling by adipocytes, nutritional induction of 
metabolic endotoxemia or reduced angiogenesis 
and local adipose cell hypoxia. Importantly, PPAR-
gamma agonists have been shown to alter macrophage 
phenotype to “M2” or an “alternatively activated” anti-
inflammatory phenotype and may induce macrophage 
specific cell death. Consequently, excitement surrounds 
the potential for specific inhibition of macrophage 
infiltration of adipose tissue via pharmacotherapy for 
obese patients and more particularly as adjunct therapy 
to improve insulin sensitivity in obese individuals with 
insulin resistance and overt type 2 diabetes.10
Over the past decade, chronic inflammation in 
visceral adipose tissue (VAT) has gained acceptance as 
a lead promoter of insulin resistance in obesity. A great 
deal of evidence has pointed to the role of adipokines 
and innate immune cells, in particular, adipose tissue 
macrophages, in the regulation of fat inflammation 
and glucose homeostasis. However, more recently, cells 
of the adaptive immune system, specifically B and T 
lymphocytes, have emerged as unexpected promoters 
and controllers of insulin resistance. These adaptive 
immune cells infiltrate obesity expanded VAT and 
through cytokine secretion and macrophage modulation 
dictate the extent of the local inflammatory response, 
thereby directly impacting insulin resistance. The 
remarkable ability of our adaptive immune system 
to regulate insulin sensitivity and metabolism has 
unmasked a novel physiological function of this system, 
and promises new diagnostic and therapeutic strategies 
to manage the disease.15
Upper body subcutaneous fat, as estimated by 
neck circumference, may confer risk above and beyond 
visceral abdominal fat. Anatomically, upper-body 
subcutaneous fat is a unique fat depot located in a 
separate compartment compared with VAT. Systemic 
free fatty acid concentrations are primarily determined 
by upper-body subcutaneous fat, suggesting that this 
fat depot may play an important role in risk factor 
pathogenesis. Elevated free fatty acid concentrations 
have been associated with insulin resistance, increased 
very-low-density lipoprotein cholesterol production, 
and endothelial cell dysfunction. Some studies 
have indicated that neck circumference may be an 
independent correlate of metabolic risk factors above 
and beyond BMI and waist circumference. In addition, 
a small study of men demonstrated that higher levels of 
upper-body subcutaneous fat, as measured by magnetic 
resonance imaging, were associated with higher low-
density lipoprotein (LDL) and lower high-density 
lipoprotein (HDL) cholesterol levels.14 In the present 
study, we also observed the lower concentrations of 
HDL-cholesterol in IR-MO subjects.
Our study found the correlation between CAC score 
and NC remained significant after adjustment of BMI, 
hs-CRP, degree of HOMA-IR or adipokines (leptin 
and adiponectin), this lead to suggestion that another 
mechanisms might be involved between increased neck 
circumference and coronary calcification.
Davies et al reported in a prospective study of 
subjects referred to a sleep clinic with symptoms 
suggesting sleep apnoea shows that neck circumference 
corrected for height is more useful as a predictor 
of obstructive sleep apnoea than general obesity.16. 
Obstructive sleep apnoea (OSA) is a very prevalent 
disorder particularly amongst middle-aged, obese 
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men. Despite the early recognition of the strong 
association between OSA and obesity, and OSA 
and cardiovascular problems, sleep apnoea has been 
treated as a local abnormality of the respiratory track 
rather than as a systemic illness. It was reported that 
the pro-inflammatory cytokines interleukin (IL)-6 
and tumour necrosis factor-alpha (TNF alpha) 
were elevated in patients with disorders of excessive 
daytime sleepiness and proposed that these cytokines 
were mediators of daytime sleepiness. Also, it was 
reported a positive correlation between IL-6 or TNF 
alpha plasma levels and the body mass index (BMI). 
In subsequent studies, it was showed that IL-6, TNF 
alpha, leptin and insulin levels were elevated in sleep 
apnoea independently of obesity and that visceral fat, 
was the primary parameter linked with sleep apnoea. 
The association of OSA with insulin resistance and 
diabetes type 2 has been confirmed since then in 
several epidemiological and clinical studies.17 OSA 
is characterized by repetitive apnea–hypopnea cycles 
during sleep, which are associated with oxygen 
desaturation and sleep disruption. Three biological 
mechanisms are thought to underpin the association of 
OSA with endothelial dysfunction and arterial disease: 
intermittent hypoxia leading to increased oxidative 
stress, systemic inflammation, and sympathetic 
activity; intrathoracic pressure changes leading to 
excessive mechanical stress on the heart and large 
artery walls; and arousal-induced reflex sympathetic 
activation with resultant repetitive blood-pressure 
rises.18. Furthermore, longer measured sleep is reported 
to be associated with lower coronary artery calcification 
incidence independently of examined potential 
mediators and confounders.19 These studies results 
raised the question of the possibility of OSA in upper 
body obesity contributing in the pathomechanisms of 
coronary calcification.
Conclusions
In the non-diabetic obese male individuals with insulin 
resistance, neck circumference are independently 
associated with coronary calcification, beyond the 
effect of body mass index, low-grade inflammation, 
the degree of insulin resistance and adipokines such 
as leptin and adiponectin. This lead to suggestion 
upper body fat deposit may associated to coronary 
calcification through mixed mechanisms, not only 
adipokines, inflammation and insulin resistance axis, 
but may also through other mechanismswhich need 
further study, such as intermittent hypoxia and shorter 
duration of sleep due to obstructive sleep apnea.
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